Identification of meaningful, actionable clinical interventions based on annotated,
curated genomic data from next generation whole genome sequencing (WGS)
is now possible. Actions include better diagnoses, better treatment options, new
body of evidence-based medicine leading to healthier lifestyle decisions.
• WGS has moved from research into clinical practice.
• Clinical utility extends beyond cancer to pharmacogenomics and metabolic
disorders.
• Advances in computer infrastructure make analysis possible.
• Cost of genomic analysis is dropping quickly and savings through targeted Dx
(diagnosis) and Tx (treatment) can be enormous.
NIH National Human Genome Research Institute
Integrating genomics into the electronic health
record has been an ongoing goal of eMerge,
the consortium funded by the National Institutes
of Health (NIH). To learn more, visit NIH National
Human Genome Research Institute.
Visit Electronic
Medical Records
and Genomics
Network (eMerge)